Results

Total Results: 1,027 records

Showing results for "drug".

181. Draft Research Plan: Human Immunodeficiency Virus (HIV): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
     November 30, 2023 - FTC DRV/r/TDF/3TC KQ 3: Regimens that are clearly outside of current U.S. practice; single-drug

182. Archived: Tuberculosis Infection, Including Bacille Calmette-Guérin Immunization: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tuberculosis-infection-screening-immunization-1996
     February 11, 2014 - but would decrease the risk of developing active disease. 33 An analysis for HIV-infected injection drug … for high-risk individuals (e.g., immigrants, medically underserved low-income populations, injection drug … Patients with possible exposure to drug-resistant TB should be treated according to current recommendations … Nationwide survey of drug-resistant tuberculosis in the United States. … Isoniazid as preventive therapy in HIV-infected intravenous drug abusers: a decision analysis.

183. Task Force Issues Final Recommendation Statement on PrEP for HIV Prevention (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hivprep-bulletin.pdf
     August 22, 2023 - professionals need to talk with all their patients about their sexual history and ask about injection drug … ); not using condoms consistently, especially with partners who are at increased risk; and sharing drug

184. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2DGd8AvVMTJwP3ttrPcnLL
     February 25, 2020 - As defined by the US Food and Drug Administration (FDA), tobacco products in- clude any product made … Results from the 2018 National Survey on Drug Use and Health. … Future: National Survey Results on Drug Use 1975-2018: 2018 Overview: Key Findings on Adolescent Drug … US Food and Drug Administration. Published 2017. … Drug Alcohol Depend. 2014;140:217-220. doi:10.1016/j. drugalcdep.2014.04.007 47.

185. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hEp2uYfD9KRhYTY5fGr8Tp
     October 15, 2018 - prophylaxis, but there are limited data on its benefits and harms.3 Currently, erythromycin is the only drug … approved by the US Food and Drug Administration for the prophylaxis of gonococcal ophthalmia neonatorum … gonococcal ophthal- mia neonatorum.10 Other Considerations Research Needs and Gaps The only available drug … approved by the US Food and Drug Admin- istration for the prevention of gonococcal ophthalmia neonatorum … Erythromycin ophthalmic ointment is the only drug approved by the US Food and Drug Administration for

186. Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mTPBWPMDqfuWvodfd5R5Ms
     November 01, 2012 - current standard of care to prevent perinatal transmission of HIV infection in the United States is a 3-drug … included at least 3 drugs reported the lowest transmission rates; 1 trial (709 participants) of various 3-drug … was similar to the rates observed in U.S. and European cohort studies (17–20) of full-course, triple-drug … or drug combination is stopped, and effective alternatives are usually available (8). … Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An

187. Archived: Screening for HIV in Pregnant Women: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
     November 15, 2012 - current standard of care to prevent perinatal transmission of HIV infection in the United States is a 3-drug … included at least 3 drugs reported the lowest transmission rates; 1 trial (709 participants) of various 3-drug … was similar to the rates observed in U.S. and European cohort studies 17-20 ) of full-course, triple-drug … or drug combination is stopped, and effective alternatives are usually available 8 . … Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An

188. Draft Research Plan: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cognitive-impairment-older-adults
     March 06, 2025 - Food and Drug Administration (alone or in combination) for the treatment of mild and/or moderate dementia … status, driving privileges, independence) KQ 5: Serious adverse events (e.g., death, serious adverse drug

189. Draft Research Plan: Serologic Screening for Genital Herpes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/genital-herpes-serologic-screening
     July 08, 2021 - frequency) of subclinical HSV-2 viral shedding KQ 6: Treatment-related adverse events (e.g., adverse drug … Food and Drug Administration; HIV=human immunodeficiency virus; HSV=herpes simplex virus; KQ=key question

190. 2017 Report to Congress | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/2017-report-congress
     January 01, 2017 - African American Women Screening for Prostate Cancer in African American Men Screening for Illicit Drug

191. Recommendation: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
     December 15, 2020 - with a very high prevalence of HBV infection (≥8%) HIV-positive persons Persons with injection drug … Periodically screen persons with continued risk for HBV infection (eg, persons with current injection drug … Tests Screening for hepatitis B should be performed with HBsAg tests approved by the US Food and Drug … Several antiviral medications are approved by the US Food and Drug Administration for treatment of chronic … Prevalence of hepatitis B virus infection among US adults aged 20–59 years with a history of injection drug

192. Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yzXkWEQV3pn95yd_pmXZXk
     December 15, 2020 - with a very high prevalence of HBV infection (≥8%) • HIV-positive persons • Persons with injection drug … Periodically screen persons with continued risk for HBV infection (eg, persons with current injection drug … Tests Screening for hepatitis B should be performed with HBsAg tests ap- proved by the US Food and Drug … Several antiviral medications are approved by the US Food and Drug Administration for treatment of chronic … Prevalence of hepatitis B virus infection among US adults aged 20-59 years with a history of injection drug

193. PII: S0749-3797(01)00266-5 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aJ-xmGLsKqLQbQsBqodKZ5
     January 01, 2001 - middle-aged people at increased risk of coronary heart disease and good evidence that lipid-lowering drug … Drug therapy is usually more effective than diet alone, but choice of treatment should consider overall … Effectiveness of Early Intervention In four large primary prevention trials, cholesterol- lowering drug … identifying individuals whose near-term risk of coronary heart disease is sufficiently high to justify drug … In a population with a 1% risk of coronary heart disease per year, drug treatment of 67 people for 5

194. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     March 14, 2014 - middle-aged people at increased risk of coronary heart disease and good evidence that lipid-lowering drug … Drug therapy is usually more effective than diet alone, but choice of treatment should consider overall … Effectiveness of Early Detection In four large primary prevention trials, cholesterol-lowering drug … identifying individuals whose near-term risk of coronary heart disease is sufficiently high to justify drug … In a population with a 1% risk of coronary heart disease per year, drug treatment of 67 people for 5

195. Primary Care Interventions to Prevent Tobacco Use in Children and Adolescents (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JdaBr_dPvbyZ4MbrG585Me
     August 01, 2013 - Primary Care Interventions to Prevent Tobacco Use in Children and Adolescents August 2013 Task Force FINAL Recommendation | 1 Understanding Task Force Recommendations Primary Care Interventions To Prevent Tobacco Use In Children And Adolescents The U.S. Preventive Services Task Force (Task Force) has issued a …

196. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for Hepatitis C Virus Infection in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hepcbulletin.pdf
     June 25, 2013 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for Hepatitis C Virus Infection in Adults U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for Hepatitis C Virus Infection in Adults WASHINGTON, D.C. – June 25, 2013 – The U.S. Preventiv…

197. Final Research Plan: Human Immunodeficiency Virus (HIV): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
     February 22, 2024 - FTC DRV/r/TDF/3TC KQ 3: Regimens that are clearly outside of current U.S. practice; single-drug

198. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
     October 22, 2015 - Food and Drug Administration–approved medications that are available for use in the United State Localized … Food and Drug Administration) Control interventions Placebo, no treatment Active comparator

199. Clinical Summary: Screening for Atrial Fibrillation With Electrocardiography (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cPT4VRq6a8QxTtRQXZBtSc
     July 31, 2018 - heart failure, prior cardiothoracic surgery, current smoking, prior stroke, sleep apnea, alcohol and drug

200. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/statin-use-in-adults-preventive-medication
     November 05, 2020 - CVD-related event or familial hyperlipidemia Interventions Statin therapy Other drugs or non-drug